************************************************************
QIAGEN N.V., a multinational biotechnology company headquartered in Germany, announced the opening of its office in Hong Kong today (July 31), following its ten years' experience in the city working with local partners and distributors.
"QIAGEN's new subsidiary in Hong Kong has been established in response to the fast developing biomedical research community here. This underlines our commitment to Hong Kong as an important hub for life science and healthcare," said Dr Frauke Ehlert, General Manager of QIAGEN China and Hong Kong.
The opening marks a substantial expansion for QIAGEN, allowing the company to better serve its local and regional customers as well as developing stronger collaboration with Hong Kong's biotechnology community. QIAGEN's Hong Kong office will also manage the distribution of products manufactured in Mainland China to various parts of the world.
"We are building a team and infrastructure to support scientists and physicians in local universities and hospitals to discover disease mechanisms and develop cures for them," said Dr Ehlert.
Acting Director-General of Investment Promotion at Invest Hong Kong, Mr Charles Ng, welcomed the opening of the company's new office. "I am delighted to see that a global biotechnology company, such as QIAGEN, has chosen Hong Kong to set up its regional office. Our location at the heart of Asia, free flow of information, excellent infrastructure and business-friendly environment are among the attributes that have attracted international enterprises to make Hong Kong their regional hub. We look forward to assisting the company's growth and development here and in the region," said Mr Ng.
QIAGEN N.V. is the leading provider of biomedical research and molecular diagnostics technologies and products. The company's products are sold to academic research markets, pharmaceutical and biotechnology companies, applied testing customers and molecular diagnostics laboratories. QIAGEN employs more than 2,000 people worldwide and its products are sold through 22 subsidiaries and a network of distributors in more than 40 countries. For more information, please visit www.qiagen.com.hk.
Invest Hong Kong is the Hong Kong Special Administrative Region Government department charged with encouraging and facilitating inward investment into the city by providing the support needed to establish or expand a business presence here. For more information: www.investhk.gov.hk.
Ends/Tuesday, July 31, 2007
Issued at HKT 19:02
NNNN
